Going public changes everything. Lockup periods, tax brackets, diversification decisions you can't undo. The SpaceX shareholders who build wealth from equity aren't the ones who react on day one. They're the ones who planned for months and years before it. Our system turns concentrated equity into a tax-optimized diversification strategy that survives volatility and builds permanent capital.
Most SpaceX shareholders treated the IPO as the finish line. It was the starting gun. Shares unlock in stages between August and December 2026, concentration is at its peak, and diversification decisions are being made under pressure: during release windows, during a 50% drawdown, with the stock hovering near its IPO price.
An IPO isn't just a liquidity event. It's the transition from worker to investor. From time-dependent compensation (salary, RSUs, ISOs) to performance-dependent wealth (portfolio returns, asset allocation). The shareholders who navigate this transition successfully aren't the ones reacting to each release date on the calendar. They're the ones executing a multi-year diversification plan built on rules, not headlines.
The problem isn't information, it's integration. You know you're concentrated. You know you need to diversify. You know taxes matter. But without a systematic framework that coordinates share price scenarios, the staged lockup schedule, tax bracket management, and concentration targets, you're left making ad-hoc decisions at the worst possible time: when stock price, unlock windows, and emotion are all screaming at once.
Model "what if SPCX is $X when my shares unlock?" scenarios. Understand your portfolio value, concentration risk, and how the trajectory so far compares to peer company IPOs.
SpaceX has now joined this data set: up roughly 67% to its post-IPO high, then down about 50%, all within its first two months of trading. Here's how peer IPOs behaved over their first six months, and what your position would be worth at the same moves:
| Company | IPO Year | IPO Price | Price After 6 Months | % Change | Your Outcome at Same % |
|---|---|---|---|---|---|
| Snowflake | 2020 | $120 | $290 | +142% | – |
| Airbnb | 2020 | $146 | $176 | +21% | – |
| Coinbase | 2021 | $381 | $258 | -32% | – |
| Rivian | 2021 | $106 | $80 | -25% | – |
Design your tax-optimized strategy to convert concentrated equity into permanent capital, starting from the release windows that are already open.
| Year | Shares Sold | Sale Price | Gross Proceeds | Capital Gains Tax | Net Proceeds | SpaceX Position |
|---|
The IPO wasn't the destination. It was the handoff from time-dependent compensation (salary, RSUs, ISOs) to performance-dependent wealth (portfolio returns, diversified assets). The shareholders who navigate this successfully follow a systematic framework, not ad-hoc decisions driven by unlock dates and daily price swings.
Use the Position Simulator to understand your portfolio value at different SPCX prices. The stock has already traded from $107 to $226 in two months. Compare to peer company outcomes. Set expectations grounded in actual post-IPO data, not hope. Know your breakeven price and concentration risk before your next release window opens.
Design your target allocation (typically 30–60% remaining SpaceX) and timeline (2–5 years). Use the Diversification Planner to model tax impact year-by-year. Set specific parameters now, shares per release window, tax reserves needed, income stacking effects, so you're executing a plan, not reacting to volatility.
Capital gains stack on top of W-2 income. Moving states, timing bonuses, deferring RSU vests, and coordinating with spouse's income all affect marginal rates. A 5% difference in effective tax rate on $5M in sales is $250K. This requires coordination with your CPA now. The final lockup release lands December 8, 2026, and how sales divide between the 2026 and 2027 tax years is the first decision on the table.
Post-IPO volatility isn't a hypothetical anymore. SPCX rallied 67% and then gave back roughly half its value inside eight weeks. Pre-defined parameters remove emotion. Sell X shares per release window regardless of price movements. Dollar-cost average your exits. Follow the plan you built when you were rational, not during a drawdown or a euphoric spike.
We build the tax-optimized plan that turns concentrated equity into permanent capital.
Talk to DerekMost SpaceX employees hold 80–95% of their net worth in one stock. That stock just fell 50% from its high in its first two months of trading. Diversification isn't pessimism, it's risk management.
Post-IPO shareholders who diversify commonly end up holding 30–60% of their portfolio in company stock long-term. There is no universally correct number, and the trade-off is structural: lower allocations reduce single-stock risk but limit participation in further upside, while higher allocations do the opposite. Where any individual lands within, or outside, that range depends on total wealth, income needs, time horizon, and risk tolerance.
Capital gains layer on top of W-2 income, pushing you into higher marginal brackets. A $500K W-2 + $1M capital gain in California means 37.1% marginal rate (23.8% federal + 13.3% CA). Spreading sales over multiple years or timing around lower-income years can save $50K-100K per $1M sold, depending on your situation.
Peer data shows IPOs swing 50–150% in their first 6–12 months: Snowflake +142%, Coinbase -32%, Rivian -25%. SPCX has already matched the pattern with a 67% rally and a 50% correction before the first lockup release. Your diversification strategy must account for this and avoid forced selling at unfavorable prices. Pre-defined parameters remove panic.
SpaceX's lockup releases in stages: up to 20% of eligible shares after Q2 earnings on August 4, additional tranches roughly every few weeks through the fall, up to 28% more after Q3 earnings, and full release around December 8, 2026. Each window is an execution day, not a planning day. If the plan isn't built before the window opens, you're deciding under pressure, with the price moving and everyone else's sell orders in the queue.
You're not "taking profits," you're converting worker equity into investor assets. From company-dependent (SpaceX stock) to performance-dependent (diversified portfolio). From restricted (lockup windows) to liquid (trade anytime). From concentrated (95% single stock) to sustainable (40% allocation).
Selling systematically over multiple years provides three benefits: tax arbitrage (spread capital gains across years to avoid bracket spikes), dollar-cost averaging (reduces the risk of selling everything at one bad price, a real risk in a stock that has already swung from $226 to $110), and behavioral discipline (pre-defined parameters prevent emotional decisions). The staged lockup schedule helps here. It forces a minimum level of pacing through December 2026, and your plan extends that discipline into 2027 and beyond. For a $2M position targeting a 40% final allocation, that means selling in measured annual tranches rather than dumping everything at the December release, potentially saving $50K–150K in taxes depending on your bracket.
If you're planning to move from California (13.3% state tax) to Texas or Florida (0% state tax), coordinate major liquidations with the move. On $5M in capital gains, that difference can be roughly $665K, depending on your situation. But this requires establishing tax domicile in the new state BEFORE the sale, at least 183 days of physical presence, change driver's license, voter registration, etc. Work with your CPA 12-18 months in advance.
Capital gains stack on top of ordinary income. If you're planning a sabbatical, career transition, or year off, time major sales during that window. A year with $100K W-2 vs. $500K W-2 can mean 8-12% lower effective rate on capital gains. On $2M in sales, that can save $160K-240K in most cases. Plan major liquidity events around predictable income changes.
If you have losses in other positions (crypto drawdown, failed startup investment, concentrated position that declined), realize those losses in the same year you're selling SpaceX stock. Losses offset gains dollar-for-dollar up to the full amount. If you're selling $2M in SpaceX stock and have $500K in unrealized losses elsewhere, realizing those losses could save roughly $119K in federal taxes (23.8% on $500K), depending on your situation.
If you're charitably inclined, donate appreciated SpaceX shares instead of cash. In most cases you get a full fair market value deduction while eliminating capital gains tax on the donated shares. In a high-income year (post-IPO liquidity + W-2), this strategy can be worth 40-50% of the donated amount in combined tax savings. Use a donor-advised fund to bunch multiple years of donations into one high-tax year for maximum benefit.
These are modeling tools, not predictions. SPCX has traded between roughly $107 and $226 since its June 12 debut at $135, a wider range in two months than most stocks see in years. Rather than anchoring on any single price, model your position at a bear case near the lows, at the IPO price, and at a recovery case, and build a diversification plan that works across all three. The value of the tool isn't pinpoint accuracy. It's making sure your plan survives the full range of outcomes.
Neither extreme is optimal for most employees. Selling everything at the first available window maximizes tax in a single year and forfeits potential upside. With the stock well below its post-IPO high, it also means realizing everything at a depressed price. Holding everything indefinitely maintains extreme concentration risk. The framework we use: determine your target allocation (typically 30–60% SpaceX long-term), then systematically diversify across the release windows and over 2–5 years to reach that target. This balances conviction with risk management.
There is no single right answer. The variables that drive the decision are total wealth, income needs, time horizon, and risk tolerance. In general, shareholders whose company stock is their only significant asset tend to land at the lower end of the 30–60% range, because a drawdown hits their entire financial picture. Shareholders with substantial assets elsewhere (real estate, other investments, a business) have more capacity to sit at the higher end. Allocations above 60% carry concentration risk that grows regardless of conviction. Use the calculator to model different targets and see the tax/concentration trade-offs.
This is the exact moment systematic diversification is designed for. Waiting for recovery is a concentrated bet that the stock returns to $226. It might, but your plan shouldn't require it. If you diversify across release windows over 2–3 years, some sales happen at lower prices and some at higher prices, and you're never forced to be right about timing. Compare that to holding everything for the perfect exit: you carry full concentration risk the entire time, and peer data (Coinbase -32%, Rivian -25% at six months) shows recoveries aren't guaranteed on any schedule. Pre-defined parameters remove the temptation to anchor on the all-time high.
ISOs complicate the math. If you exercised before the IPO, your cost basis is your strike price, likely far below today's market price, which means larger capital gains at exit. On the other hand, your long-term capital gains clock may already be running or complete. If you haven't exercised yet, the decision now involves the public market price, AMT exposure on the spread at exercise, the disqualifying disposition rules if you sell within a year of exercise (or two years of grant), and your release-window timeline. The calculator above uses a simplified cost basis input; ISO strategies require lot-level modeling and coordination with your CPA.
The lockup releases in stages rather than on a single date. Per the S-1, up to 20% of eligible shares become transferable shortly after Q2 2026 earnings, scheduled for August 4. Additional tranches of up to 7% each release at set intervals through the fall, up to 28% more becomes available after Q3 earnings, and all remaining restrictions lift 180 days after the offering, around December 8, 2026. A performance-based tranche of an additional 10% required the stock to close at least 30% above the $135 IPO price heading into the first earnings release, which at current prices did not trigger. Current employees also remain subject to SpaceX's insider trading policy and open trading windows, so your personal sell dates may be narrower than the lockup schedule alone suggests. Confirm your specific eligible shares and windows in Morgan Stanley at Work before building your execution plan around them.
These tools provide the framework, but implementing a multi-year, tax-optimized diversification strategy requires coordination across CPA, estate planning, and portfolio construction.
We specialize in guiding SpaceX equity holders through exactly this transition: from concentrated worker equity, through the lockup windows, to diversified permanent capital.
Talk to Derek
